Cocrystal Pharma, INC Schedule 13D activist filings

Key investors, including OPKO Health and entities controlled by Dr. Phillip Frost, have collectively increased their beneficial ownership in Cocrystal Pharma, Inc., signaling strong conviction in the company's prospects.

Phillip Frost, M.D. and Frost Gamma Investments Trust have amended their Schedule 13D filing to report an increase in beneficial ownership of Cocrystal Pharma, Inc. common stock.

Phillip Frost, M.D. and Frost Gamma Investments Trust increased their beneficial ownership in Cocrystal Pharma, Inc. through a recent unit purchase.

Phillip Frost, M.D. and Frost Gamma Investments Trust reported an increased beneficial ownership in Cocrystal Pharma, Inc. to 10.6% following RSU vesting.